-
Mashup Score: 0
“One of the main summaries/focuses of this discussion was, how do we create action to improve screening, and what that actually means,” says Samuel L. Washington III, MD, MAS.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Apalutamide holds potential in NMIBC, expert says - 3 hour(s) ago
“So, there’s a lot of evidence to point to the androgen receptor being an important player in at least developing this disease,” says Edward M. Messing, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Urology Times Journal - 1 day(s) ago
Urology Times® delivers analysis, perspectives, and practical advice about current health policy issues, clinical advances, and business challenges to urologists and allied health professionals. Each issue provides updates on clinical advances in malignant and benign urologic disease, health policy, legislation, malpractice, coding, and more. Click Here to Subscribe
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 10
“So I think these findings overall are reassuring and support the use of neuromodulation in this population,” says Leo Dreyfuss, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 6
“Our results demonstrated that treatment with [the] Optilume BPH procedure resulted in significant symptom relief while still preserving erectile and ejaculatory function,” said Olivia Copelan, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1Dosing commences in phase 1/2 trial of AB-2100 in ccRCC - 2 day(s) ago
The dose escalation/dose expansion study is evaluating the safety and efficacy of AB-2100 in patients with ccRCC who either came back or did not improve following prior treatment with a checkpoint inhibitor and a VEGF inhibitor.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0
“The association of lower testosterone concentrations with higher all-cause mortality was present irrespective of luteinizing hormone concentrations, indicating that low testosterone was the main factor,” says Bu B. Yeap, MBBS, FRACP, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 10
“Also, the technique lends itself really nicely to these, what we call posterior ball-valve tumors, which are these tumors that sit behind the renal hilum, behind the blood vessels on the posterior side of the kidney,” says Alexander Kutikov, MD, FACS.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 4
“The 2018 AUA guidelines for testosterone therapy that were co-chaired by Dr. John P. Mulhall say that we have an absence or a paucity of data on using testosterone therapy on active surveillance,” says Helen L. Bernie, DO, MPH.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3
“The biggest take home point is that patients with node-positive disease at the time of radical prostatectomy are a heterogeneous group of patients,” says Daniel A. Triner, MD, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
Dr. Samuel L. Washington shares key takeaways from an #AUA24 session on prostate cancer screening in Black and Brown communities. @SamWashUro @UCSFUrology #pcsm #urology https://t.co/6fYQbL5goA